ClinicalTrials.Veeva

Menu

Endoscopic Resection of Early Esophageal Tumors in the Context of Cirrhosis or Portal Hypertension

C

Central Hospital, Nancy, France

Status

Completed

Conditions

Portal Hypertension
Cirrhosis
Esophageal Neoplasms

Treatments

Procedure: Endosocpic resection of early esophageal tumor

Study type

Observational

Funder types

Other

Identifiers

NCT04994548
2019PI67

Details and patient eligibility

About

Cirrhotic patients may be at high risk for esophageal cancer. Endoscopic resection is the standard treatment for superficial tumors. However, cirrhosis might be associated with upper gastrointestinal bleeding, particularly in case of portal hypertension or coagulopathy. This study aims to assess safety, efficacy and methods to prevent potential complications in cirrhosis or portal hypertension context for esophageal endoscopic resection.

This retrospective multicentric French-Belgian study includes all consecutive patients with cirrhosis or portal hypertension who underwent esophageal endoscopic resection from January 2005 to 2021.

Enrollment

112 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • older than 18 years with cirrhosis or portal hypertension who underwent endoscopic resection of an early esophageal tumor

Exclusion criteria

  • younger than 18

Trial design

112 participants in 1 patient group

Cirrhotic patients or with portal hypertension
Description:
Patients with early esophageal cancer
Treatment:
Procedure: Endosocpic resection of early esophageal tumor

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems